News & Perspective

Nov 09, 2012

Nov 09, 2012

BioCryst may drop quest for US approval of peramivir

(CIDRAP News) – BioCryst Pharmaceuticals Inc. signaled yesterday it will probably give up on seeking a US license for the influenza drug peramivir, a move that would reduce the already limited options for severely ill flu patients in need of an intravenous antiviral drug.

Oct 02, 2013

Oct 02, 2013
flu vaccine vial

HHS: Fill-and-finish contracts will boost flu vaccine capacity

New federal contracts establish a "fill and finish" network for flu vaccine to boost capacity by 20%.

Jun 16, 2014

Jun 16, 2014
Novartis Holly Springs

FDA OKs Novartis's US cell-based flu vaccine facility

The agency has approved a plant in Holly Springs, N.C.

Sep 15, 2014

Sep 15, 2014
Africa medical aid

UN security council to hold emergency Ebola talks

US lawmakers will hear from federal officials, ahead of an emergency UN Security Council meeting on Ebola.

Oct 01, 2014

Oct 01, 2014

News Scan for Oct 01, 2014

Funds for new flu tests
Simvastatin for ARDS
Flawed FEMA system

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by

  Become an underwriter»